| Liza A Ystaas, FNP-C | |
|
3883 74th Ave Ne, Fort Totten, ND 58335 | |
| (701) 766-1600 | |
| Not Available |
| Full Name | Liza A Ystaas |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 4 Years |
| Location | 3883 74th Ave Ne, Fort Totten, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124646146 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | R34544 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cooperstown Medical Center | Cooperstown, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cooperstown Medical Center | 5698687689 | 5 |
News Archive
Every year, thousands of babies are born with severely malformed hearts, disorders known collectively as congenital heart disease. Many of these defects can be repaired though surgery, but researchers don't understand what causes them or how to prevent them. New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
Mylan Inc. today confirmed that it was sued by Pfizer in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, 2.5/20 mg, 2.5/40 mg, 5/10 mg, 5/20 mg, 5/40 mg, 5/80 mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg.
A specific genetic defect in one Chinese family shows that high blood pressure was inherited from the female parent, researchers report in Circulation Research: Journal of the American Heart Association.
A gene better known for its role in preventing cancer also plays a key role in the developing embryo, where the gene prevents excessive growth of blood vessels, according to investigators at St. Jude Children's Research Hospital.
PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company TTY Biopharm to market and distribute the drug candidate APLIDIN (plitidepsin) in Taiwan. Under the terms of the agreement, PharmaMar will receive an upfront payment, royalties and additional remunerations for regulatory milestones achieved by APLIDIN (plitidepsin).
› Verified 1 days ago
| Entity Name | Mckenzie County Healthcare Systems Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063420495 PECOS PAC ID: 5890768006 Enrollment ID: O20040817000016 |
News Archive
Every year, thousands of babies are born with severely malformed hearts, disorders known collectively as congenital heart disease. Many of these defects can be repaired though surgery, but researchers don't understand what causes them or how to prevent them. New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
Mylan Inc. today confirmed that it was sued by Pfizer in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, 2.5/20 mg, 2.5/40 mg, 5/10 mg, 5/20 mg, 5/40 mg, 5/80 mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg.
A specific genetic defect in one Chinese family shows that high blood pressure was inherited from the female parent, researchers report in Circulation Research: Journal of the American Heart Association.
A gene better known for its role in preventing cancer also plays a key role in the developing embryo, where the gene prevents excessive growth of blood vessels, according to investigators at St. Jude Children's Research Hospital.
PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company TTY Biopharm to market and distribute the drug candidate APLIDIN (plitidepsin) in Taiwan. Under the terms of the agreement, PharmaMar will receive an upfront payment, royalties and additional remunerations for regulatory milestones achieved by APLIDIN (plitidepsin).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Liza A Ystaas, FNP-C 421 14th St N, New Rockford, ND 58356-1103 Ph: (701) 341-0740 | Liza A Ystaas, FNP-C 3883 74th Ave Ne, Fort Totten, ND 58335 Ph: (701) 766-1600 |
News Archive
Every year, thousands of babies are born with severely malformed hearts, disorders known collectively as congenital heart disease. Many of these defects can be repaired though surgery, but researchers don't understand what causes them or how to prevent them. New research shows that about 10 percent of these defects are caused by genetic mutations that are absent in the parents of affected children.
Mylan Inc. today confirmed that it was sued by Pfizer in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, 2.5/20 mg, 2.5/40 mg, 5/10 mg, 5/20 mg, 5/40 mg, 5/80 mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg.
A specific genetic defect in one Chinese family shows that high blood pressure was inherited from the female parent, researchers report in Circulation Research: Journal of the American Heart Association.
A gene better known for its role in preventing cancer also plays a key role in the developing embryo, where the gene prevents excessive growth of blood vessels, according to investigators at St. Jude Children's Research Hospital.
PharmaMar has entered into an exclusive license and commercialization agreement with the pharmaceutical company TTY Biopharm to market and distribute the drug candidate APLIDIN (plitidepsin) in Taiwan. Under the terms of the agreement, PharmaMar will receive an upfront payment, royalties and additional remunerations for regulatory milestones achieved by APLIDIN (plitidepsin).
› Verified 1 days ago
Mikkel Elizabeth Buckmier, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Cheryl A. Hefta, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 416 2nd Ave N, Fort Totten, ND 58335 Phone: 701-766-1251 Fax: 701-766-1260 | |
Kristen Renae Gourneau, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3883 74th Avenue, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Macie Mikkelsen, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Worku Metaferia, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 | |
Kimberly Ann Brown, MSN, APRN, FNP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3883 74th Ave Ne, Fort Totten, ND 58335 Phone: 701-766-1600 |